ARVEE — Arvee Laboratories (India) Balance Sheet
0.000.00%
- IN₹1.64bn
- IN₹1.56bn
- IN₹303.45m
Annual balance sheet for Arvee Laboratories (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 40.7 | 86.4 | 31.1 | 8.92 | 18.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 75.5 | 78.8 | 122 | 123 | 61.3 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 181 | 256 | 222 | 216 | 168 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 149 | 147 | 148 | 142 | 153 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 336 | 410 | 387 | 387 | 382 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 126 | 183 | 133 | 88.4 | 69.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 149 | 196 | 147 | 106 | 90.8 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 187 | 214 | 239 | 281 | 291 |
Total Liabilities & Shareholders' Equity | 336 | 410 | 387 | 387 | 382 |
Total Common Shares Outstanding |